Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
Article Date
March 10, 2026
This article is featured on another website.
Go to article
January 26, 2026
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…
January 26, 2026
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…